2022 American Academy of Ophthalmology Meeting, Retina Subspecialty
September 30, 2022 2:48 PM PDT
Title: KSI-301 Anti-VEGF Antibody Biopolymer Conjugate for Retinal Vein Occlusion: Primary and Secondary 24- Week Efficacy and Safety Outcomes of the BEACON Phase 3 Pivotal Study
Presenter: Michael A Singer, M.D., Clinical Professor of Ophthalmology, University of Texas Health Science Center, and Director of Clinical Research, Medical Center Ophthalmology Associates, San Antonio, TX
Presenter: Michael A Singer, M.D., Clinical Professor of Ophthalmology, University of Texas Health Science Center, and Director of Clinical Research, Medical Center Ophthalmology Associates, San Antonio, TX
Supporting Materials
Location
Chicago, Illinois